Scope and limitations of the co-drug approach to topical drug delivery.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current pharmaceutical design

• Publication date

  2008-02-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/138161208784007653PMID 18393881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting different signaling pathways with antisense oligonucleotides combination for cancer therapy.

  2007cited by this paper
• Angiotensin-converting enzyme inhibitors in veterinary medicine.

  2007cited by this paper
• A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results

  2006cited by this paper
• Sensor/effector drug design with potential relevance to cancer.

  2006cited by this paper
• Enhancement of transdermal delivery of 6-beta-naltrexol via a codrug linked to hydroxybupropion.

  2006cited by this paper
• Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy

  2006cited by this paper
• Synthesis and hydrolytic behavior of two novel tripartate codrugs of naltrexone and 6beta-naltrexol with hydroxybupropion as potential alcohol abuse and smoking cessation agents.

  2006cited by this paper
• L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties.

  2006cited by this paper
• Novel antiglaucoma prodrugs and codrugs of ethacrynic acid.

  2005cited by this paper
• Topical delivery of retinyl ascorbate co-drug: 6. Determination of toxic dose and antioxidant activity in cultured human epidermal keratinocytes.

  2005cited by this paper
• Evaluation of O(3alpha)-, O(21)-di-(N(1)-methyloxycarbonyl-2, 4-dioxo-5-fluoropyrimidinyl) 17alpha-hydroxy-5beta-pregnan-20-one as a novel potential antiangiogenic codrug.

  2005cited by this paper
• Topical delivery of retinyl ascorbate: 4. Comparative anti-oxidant activity towards DPPH

  2005cited by this paper
• Vitamin D3–Based Conjugates for Topical Treatment of Psoriasis: Synthesis, Antiproliferative Activity, and Cutaneous Penetration Studies

  2004cited by this paper
• A duplex "Gemini" prodrug of naltrexone for transdermal delivery.

  2004cited by this paper
• Penetration enhancers.

  2004cited by this paper
• Alpha-tocopherol pro-vitamins: synthesis, hydrolysis and accumulation in rabbit ear skin.

  2004cited by this paper
• Novel mutual pro-drugs of 2′,3′-dideoxyinosine with 3-octadecyloxy-propane-1,2-diol by straightforward enzymatic regioselective synthesis in acetone

  2004cited by this paper
• Microneedles for transdermal drug delivery.

  2004cited by this paper
• Efficacy of once‐daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris

  2004cited by this paper
• Topical delivery of retinyl ascorbate co-drug. 1. Synthesis, penetration into and permeation across human skin.

  2004cited by this paper
• Topical Delivery of Retinyl Ascorbate Co-Drug

  2004cited by this paper
• Combination therapy to treat moderate to severe psoriasis.

  2004cited by this paper
• Topical Delivery of Retinyl Ascorbate Co-Drug

  2004cited by this paper
• Design and synthesis of a novel L-dopa-entacapone codrug.

  2002cited by this paper
• Biological and metabolic study of naproxen-propyphenazone mutual prodrug.

  2002cited by this paper
• Percutaneous penetration and skin metabolism of ethylsalicylate-containing agent, TU-2100: in-vitro and in-vivo evaluation in guinea pigs.

  2002cited by this paper
• Novel mechanisms and devices to enable successful transdermal drug delivery.

  2001cited by this paper
• In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac.

  2001cited by this paper
• Antioxidants and vitamins in cosmetics.

  2001cited by this paper
• Antiviral drugs: current state of the art.

  2001cited by this paper
• The 500 Dalton rule for the skin penetration of chemical compounds and drugs

  2000cited by this paper
• Novel mutual prodrug of retinoic and butyric acids with enhanced anticancer activity.

  2000cited by this paper
• Valaciclovir

  2000cited by this paper
• Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis

  1999cited by this paper
• Improving the pharmacokinetic and pharmacodynamic properties of a drug by chemical conversion to a chimera drug.

  1999cited by this paper
• Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.

  1999cited by this paper
• Transdermal permeation of neutral molecules by skin electroporation.

  1998cited by this paper
• Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724).

  1998cited by this paper
• Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.

  1996cited by this paper
• Physical enhancement of dermatologic drug delivery: iontophoresis and phonophoresis.

  1996cited by this paper
• Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin.

  1994cited by this paper
• Structure-permeability relationships in percutaneous penetration.

  1992cited by this paper
• Antimicrobial spectrum of cefpirome combined with tazobactam against the Bacteroides fragilis group.

  1990cited by this paper
• Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime

  1989cited by this paper

• A berberine-loaded hydrogel for the treatment of atopic dermatitis through antibacterial activity, inhibition of inflammation and modulation of oxidative stress

  2026cites this paper
• Synthesis of Enantiostructured Triacylglycerols Possessing a Saturated Fatty Acid, a Polyunsaturated Fatty Acid and an Active Drug Intended as Novel Prodrugs

  2024cites this paper
• A review on natural biopolymers in external drug delivery systems for wound healing and atopic dermatitis.

  2024cites this paper
• The Promoting Effect of Animal Bioactive Proteins and Peptide Components on Wound Healing: A Review

  2024cites this paper
• smProdrugs: A repository of small molecule prodrugs.

  2023cites this paper
• Synthesis and Evaluation of Amide Codrug of Ibuprofen and Amlodipine for Dual Inhibition of Inflammation and Hypertension

  2023cites this paper
• Nanoemulgel: A Novel Nano Carrier as a Tool for Topical Drug Delivery

  2023cites this paper
• Mutual Prodrugs - Codrugs.

  2022cites this paper
• 5-[(3-Carboxy-4-hydroxyphenyl)diazenyl] nicotinic acid, an azo-linked mesalazine-nicotinic acid conjugate, is a colon-targeted mutual prodrug against dextran sulfate sodium-induced colitis in mice

  2021cites this paper
• Seaweeds Compounds: An Ecosustainable Source of Cosmetic Ingredients?

  2021cites this paper
• Functionalized graphene oxide as a vehicle for targeted drug delivery and bioimaging applications.

  2020cites this paper
• 5-Aminosalicylic Acid Azo-coupled with a GPR109A Agonist Is a Colon-targeted Anti-colitic Codrug with a Reduced Risk of Skin Toxicity.

  2019cites this paper
• Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis

  2019cites this paper
• The Pharmacokinetics of Fucoidan after Topical Application to Rats

  2019influential citation
• Development of methotrexate loaded fucoidan/chitosan nanoparticles with anti-inflammatory potential and enhanced skin permeation.

  2019cites this paper
• Site-specific drug delivery in the skin for the localized treatment of skin diseases

  2019cites this paper
• Anti-Inflammatory Effect and Skin Toxicity of Aqueous Extract of Dorema ammoniacum Gum in Experimental Animals

  2018cites this paper
• DESIGN, SYNTHESIS AND CHEMICAL HYDROLYSIS STUDY OF CODRUGS OF PROPRANOLOL WITH METFORMIN.

  2018cites this paper
• Topical drug therapeutics for neuropathic pain

  2018cites this paper
• Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs.

  2017cites this paper
• Topical peptides as cosmeceuticals

  2017cites this paper
• Prodrugs of triterpenoids and their derivatives.

  2017cites this paper
• CORRELATION APPROACH OF PRO-DRUG AND CO-DRUG IN BIOTRANSFORMATION

  2017cites this paper
• Aerosol Delivery Enhances Percutaneous Permeability of Epidermal Growth Factor and Thioredoxin

  2016cites this paper
• Synthesis of (125) I-lamivudine and (125) I-lamivudine-ursodeoxycholic acid codrug.

  2016cites this paper
• The codrug approach for facilitating drug delivery and bioactivity

  2016cites this paper
• Chemoselective Protection of Glutathione in the Preparation of Bioconjugates: The Case of Trypanothione Disulfide.

  2016cites this paper
• Effects of Geranyloxycinnamic Acids on COX-2 and iNOS Functionalities in LPS-Stimulated U937 Mononuclear Cells

  2016cites this paper
• Skin autoimmune disorders: lipid biopolymers and colloidal delivery systems for topical delivery

  2016cites this paper
• Nanomiemgel - A Novel Drug Delivery System for Topical Application - In Vitro and In Vivo Evaluation

  2014cites this paper
• Chapter 9 – Prodrugs and Drug Delivery Systems

  2014cites this paper
• Stability, cutaneous delivery, and antioxidant potential of a lipoic acid and α-tocopherol codrug incorporated in microemulsions.

  2014cites this paper
• Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS)

  2014cites this paper
• Chapter Twenty-Four - Glossary of Terms Used in Medicinal Chemistry Part II (IUPAC Recommendations 2013)

  2013cites this paper
• Optimization of Naltrexone Diclofenac Codrugs for Sustained Drug Delivery Across Microneedle-Treated Skin

  2013cites this paper
• Design, Synthesis and in Vitro Degradation of a Novel Co-Drug for the Treatment of Psoriasis

  2013cites this paper
• Synthesis and anticancer activity of dichloroplatinum(II) complexes of podophyllotoxin.

  2013cites this paper
• Mechanochemical preparation of co-crystals.

  2013cites this paper
• SYNTHESIS AND STABILITY STUDIES OF PRODRUGS AND CODRUGS OF NALTREXONE AND 6-β-NALTREXOL

  2013cites this paper
• Synthesis, crystal structure and biological activities of naproxen-eugenol ester prodrug

  2013cites this paper
• Glossary of terms used in medicinal chemistry. Part II (IUPAC Recommendations 2013)

  2013cites this paper
• Formulation Optimization for Pore Lifetime Enhancement and Sustained Drug Delivery Across Microneedle Treated Skin

  2013cites this paper
• Distribution of esterase activity in porcine ear skin, and the effects of freezing and heat separation.

  2012cites this paper
• Combining piracetam and lithium salts: ionic co-crystals and co-drugs?

  2012cites this paper
• The co-drug of conjugated hydroquinone and azelaic acid to enhance topical skin targeting and decrease penetration through the skin.

  2012cites this paper
• Synthesis, stability and pharmacological evaluation of a novel codrug consisting of lamivudine and ursolic acid.

  2012cites this paper
• Therapeutic and cytotoxic effects of the novel antipsoriasis codrug, naproxyl-dithranol, on HaCaT cells.

  2011cites this paper
• Topically applied KTTKS: a review

  2011cites this paper
• Topical Delivery of a Naproxen-Dithranol Co-drug: In Vitro Skin Penetration, Permeation, and Staining

  2010cites this paper
• Codrug: an efficient approach for drug optimization.

  2010cites this paper
• Self-assembled drug delivery systems. Part 5: self-assemblies of a bolaamphiphilic prodrug containing dual zidovudine.

  2010cites this paper
• Signalling pathways activated by ultraviolet radiation: role in ocular and cutaneous health.

  2010cites this paper
• Prodrug Approach for Increasing Cellular Glutathione Levels

  2010cites this paper
• Current prodrug design for drug discovery.

  2009cites this paper
• Skin tests in the diagnosis of drug hypersensitivity reactions.

  2008cites this paper